128 related articles for article (PubMed ID: 17467669)
1. Solution structure of the first SH3 domain of human vinexin and its interaction with vinculin peptides.
Zhang J; Li X; Yao B; Shen W; Sun H; Xu C; Wu J; Shi Y
Biochem Biophys Res Commun; 2007 Jun; 357(4):931-7. PubMed ID: 17467669
[TBL] [Abstract][Full Text] [Related]
2. Structural investigation of the interaction between the tandem SH3 domains of c-Cbl-associated protein and vinculin.
Zhao D; Wang X; Peng J; Wang C; Li F; Sun Q; Zhang Y; Zhang J; Cai G; Zuo X; Wu J; Shi Y; Zhang Z; Gong Q
J Struct Biol; 2014 Aug; 187(2):194-205. PubMed ID: 24878663
[TBL] [Abstract][Full Text] [Related]
3. Vinexin: a novel vinculin-binding protein with multiple SH3 domains enhances actin cytoskeletal organization.
Kioka N; Sakata S; Kawauchi T; Amachi T; Akiyama SK; Okazaki K; Yaen C; Yamada KM; Aota S
J Cell Biol; 1999 Jan; 144(1):59-69. PubMed ID: 9885244
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the second SH3 domain of human CMS and a newly identified binding site at the C-terminus of c-Cbl.
Yao B; Zhang J; Dai H; Sun J; Jiao Y; Tang Y; Wu J; Shi Y
Biochim Biophys Acta; 2007 Jan; 1774(1):35-43. PubMed ID: 17188587
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
Wybenga-Groot LE; McGlade CJ
Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
[TBL] [Abstract][Full Text] [Related]
6. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
Liu J; Li M; Ran X; Fan JS; Song J
Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
[TBL] [Abstract][Full Text] [Related]
7. Solution NMR structure and ligand identification of human Gas7 SH3 domain reveal a typical SH3 fold but a non-canonical ligand-binding mode.
Nie Y; Zhu J; Ramelot TA; Kennedy MA; Liu M; He T; Yang Y
Biochem Biophys Res Commun; 2019 Sep; 516(4):1190-1195. PubMed ID: 31296381
[TBL] [Abstract][Full Text] [Related]
8. Solution structure and peptide binding of the SH3 domain from human Fyn.
Morton CJ; Pugh DJ; Brown EL; Kahmann JD; Renzoni DA; Campbell ID
Structure; 1996 Jun; 4(6):705-14. PubMed ID: 8805554
[TBL] [Abstract][Full Text] [Related]
9. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
Gosser YQ; Zheng J; Overduin M; Mayer BJ; Cowburn D
Structure; 1995 Oct; 3(10):1075-86. PubMed ID: 8590002
[TBL] [Abstract][Full Text] [Related]
10. Structural Basis of the High Affinity Interaction between the Alphavirus Nonstructural Protein-3 (nsP3) and the SH3 Domain of Amphiphysin-2.
Tossavainen H; Aitio O; Hellman M; Saksela K; Permi P
J Biol Chem; 2016 Jul; 291(31):16307-17. PubMed ID: 27268056
[TBL] [Abstract][Full Text] [Related]
11. Solution NMR Structure of the SH3 Domain of Human Caskin1 Validates the Lack of a Typical Peptide Binding Groove and Supports a Role in Lipid Mediator Binding.
Tőke O; Koprivanacz K; Radnai L; Merő B; Juhász T; Liliom K; Buday L
Cells; 2021 Jan; 10(1):. PubMed ID: 33467043
[TBL] [Abstract][Full Text] [Related]
12. Directed discovery of bivalent peptide ligands to an SH3 domain.
Ferguson MR; Fan X; Mukherjee M; Luo J; Khan R; Ferreon JC; Hilser VJ; Shope RE; Fox RO
Protein Sci; 2004 Mar; 13(3):626-32. PubMed ID: 14978303
[TBL] [Abstract][Full Text] [Related]
13. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
Han S; Liu Q; Wang F; Yuan Z
J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the N-terminal SH3 domain of Nck-alpha and CD3-epsilon-derived peptides: non-canonical and canonical recognition motifs.
Santiveri CM; Borroto A; Simón L; Rico M; Alarcón B; Jiménez MA
Biochim Biophys Acta; 2009 Jan; 1794(1):110-7. PubMed ID: 18955169
[TBL] [Abstract][Full Text] [Related]
15. Solution structure and ligand-binding site of the carboxy-terminal SH3 domain of GRB2.
Kohda D; Terasawa H; Ichikawa S; Ogura K; Hatanaka H; Mandiyan V; Ullrich A; Schlessinger J; Inagaki F
Structure; 1994 Nov; 2(11):1029-40. PubMed ID: 7881903
[TBL] [Abstract][Full Text] [Related]
16. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
17. Recognition of non-canonical peptides by the yeast Fus1p SH3 domain: elucidation of a common mechanism for diverse SH3 domain specificities.
Kim J; Lee CD; Rath A; Davidson AR
J Mol Biol; 2008 Mar; 377(3):889-901. PubMed ID: 18280496
[TBL] [Abstract][Full Text] [Related]
18. Site-specific protein backbone and side-chain NMR chemical shift and relaxation analysis of human vinexin SH3 domain using a genetically encoded 15N/19F-labeled unnatural amino acid.
Shi P; Xi Z; Wang H; Shi C; Xiong Y; Tian C
Biochem Biophys Res Commun; 2010 Nov; 402(3):461-6. PubMed ID: 20946873
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain.
Malki I; Cantrelle FX; Sottejeau Y; Lippens G; Lambert JC; Landrieu I
FEBS J; 2017 Oct; 284(19):3218-3229. PubMed ID: 28755476
[TBL] [Abstract][Full Text] [Related]
20. A lack of peptide binding and decreased thermostability suggests that the CASKIN2 scaffolding protein SH3 domain may be vestigial.
Kwan JJ; Donaldson LW
BMC Struct Biol; 2016 Sep; 16(1):14. PubMed ID: 27619958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
